Quidel Corporation (NASDAQ:QDEL) had its price target upped by Barclays PLC from $45.00 to $49.00 in a research report issued on Thursday. The firm currently has an “overweight” rating on the stock. Barclays PLC’s price target would suggest a potential upside of 19.66% from the company’s previous close.

Several other equities analysts also recently weighed in on QDEL. TheStreet upgraded Quidel Corporation from a “c+” rating to a “b-” rating in a research report on Thursday, July 6th. BidaskClub downgraded Quidel Corporation from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 16th. Zacks Investment Research upgraded Quidel Corporation from a “hold” rating to a “buy” rating and set a $30.00 target price on the stock in a research report on Tuesday, July 18th. Canaccord Genuity upgraded Quidel Corporation from a “hold” rating to a “buy” rating in a research report on Tuesday, July 18th. Finally, William Blair upgraded Quidel Corporation from a “market perform” rating to an “outperform” rating in a research report on Tuesday, July 18th. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Quidel Corporation currently has an average rating of “Buy” and a consensus target price of $48.80.

Quidel Corporation (NASDAQ:QDEL) last released its earnings results on Wednesday, November 1st. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.21). The firm had revenue of $50.89 million during the quarter, compared to analysts’ expectations of $50.47 million. Quidel Corporation had a negative net margin of 0.03% and a negative return on equity of 0.03%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.10 EPS.

TRADEMARK VIOLATION NOTICE: “Barclays PLC Increases Quidel Corporation (QDEL) Price Target to $49.00” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/11/02/barclays-plc-increases-quidel-corporation-qdel-price-target-to-49-00.html.

In related news, CEO Douglas C. Bryant sold 12,000 shares of Quidel Corporation stock in a transaction that occurred on Thursday, September 28th. The stock was sold at an average price of $42.86, for a total transaction of $514,320.00. Following the transaction, the chief executive officer now owns 296,493 shares in the company, valued at $12,707,689.98. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Douglas C. Bryant sold 36,000 shares of Quidel Corporation stock in a transaction that occurred on Friday, September 29th. The stock was sold at an average price of $42.91, for a total value of $1,544,760.00. Following the transaction, the chief executive officer now owns 296,493 shares in the company, valued at approximately $12,722,514.63. The disclosure for this sale can be found here. In the last quarter, insiders have sold 120,000 shares of company stock worth $4,806,240. 22.00% of the stock is currently owned by company insiders.

A number of institutional investors have recently made changes to their positions in QDEL. Chicago Equity Partners LLC purchased a new position in Quidel Corporation during the second quarter worth approximately $5,062,000. Marshall Wace North America L.P. lifted its position in Quidel Corporation by 370.1% during the second quarter. Marshall Wace North America L.P. now owns 171,800 shares of the company’s stock worth $4,639,000 after buying an additional 135,253 shares in the last quarter. Renaissance Technologies LLC lifted its position in Quidel Corporation by 27.6% during the second quarter. Renaissance Technologies LLC now owns 612,487 shares of the company’s stock worth $16,623,000 after buying an additional 132,587 shares in the last quarter. Janus Henderson Group PLC purchased a new position in Quidel Corporation during the second quarter worth approximately $3,536,000. Finally, Acadian Asset Management LLC purchased a new position in Quidel Corporation during the second quarter worth approximately $3,250,000. Hedge funds and other institutional investors own 86.92% of the company’s stock.

Quidel Corporation Company Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Analyst Recommendations for Quidel Corporation (NASDAQ:QDEL)

Receive News & Ratings for Quidel Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corporation and related companies with MarketBeat.com's FREE daily email newsletter.